Sino Medical Sciences Technology In (SHG:688108) — Market Cap & Net Worth
Market Cap & Net Worth: Sino Medical Sciences Technology In (688108)
Sino Medical Sciences Technology In (SHG:688108) has a market capitalization of $1.33 Billion (CN¥9.10 Billion) as of May 7, 2026. Listed on the SHG stock exchange, this China-based company holds position #7924 globally and #1989 in its home market, demonstrating a 3.27% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Sino Medical Sciences Technology In's stock price CN¥21.78 by its total outstanding shares 417952000 (417.95 Million). Analyse 688108 cash flow conversion to see how efficiently the company converts income to cash.
Sino Medical Sciences Technology In Market Cap History: 2019 to 2026
Sino Medical Sciences Technology In's market capitalization history from 2019 to 2026. Data shows change from $991.07 Million to $1.33 Billion (-0.25% CAGR).
Sino Medical Sciences Technology In Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Sino Medical Sciences Technology In's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
1.30x
Sino Medical Sciences Technology In's market cap is 1.30 times its annual revenue
Latest Price to Earnings (P/E) Ratio
398.53x
Sino Medical Sciences Technology In's market cap is 398.53 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2019 | $991.07 Million | $435.91 Million | $90.04 Million | 2.27x | 11.01x |
| 2020 | $823.82 Million | $327.42 Million | $22.49 Million | 2.52x | 36.63x |
| 2021 | $502.12 Million | $194.36 Million | -$130.77 Million | 2.58x | N/A |
| 2022 | $349.22 Million | $192.85 Million | -$162.38 Million | 1.81x | N/A |
| 2023 | $767.55 Million | $343.26 Million | -$39.63 Million | 2.24x | N/A |
| 2024 | $596.92 Million | $458.74 Million | $1.50 Million | 1.30x | 398.53x |
Competitor Companies of 688108 by Market Capitalization
Companies near Sino Medical Sciences Technology In in the global market cap rankings as of May 7, 2026.
Key companies related to Sino Medical Sciences Technology In by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #151 globally with a market cap of $150.06 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #211 globally with a market cap of $111.87 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #230 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
- Medtronic PLC (XETRA:2M6): Ranked #246 globally with a market cap of $99.67 Billion USD ( €85.25 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #151 | Abbott Laboratories | NYSE:ABT | $150.06 Billion | $86.30 |
| #211 | Stryker Corporation | NYSE:SYK | $111.87 Billion | $292.33 |
| #230 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
| #246 | Medtronic PLC | XETRA:2M6 | $99.67 Billion | €66.40 |
Sino Medical Sciences Technology In Historical Marketcap From 2019 to 2026
Between 2019 and today, Sino Medical Sciences Technology In's market cap moved from $991.07 Million to $ 1.33 Billion, with a yearly change of -0.25%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CN¥1.33 Billion | +13.20% |
| 2025 | CN¥1.18 Billion | +97.13% |
| 2024 | CN¥596.92 Million | -22.23% |
| 2023 | CN¥767.55 Million | +119.79% |
| 2022 | CN¥349.22 Million | -30.45% |
| 2021 | CN¥502.12 Million | -39.05% |
| 2020 | CN¥823.82 Million | -16.88% |
| 2019 | CN¥991.07 Million | -- |
End of Day Market Cap According to Different Sources
On May 7th, 2026 the market cap of Sino Medical Sciences Technology In was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $1.33 Billion USD |
| MoneyControl | $1.33 Billion USD |
| MarketWatch | $1.33 Billion USD |
| marketcap.company | $1.33 Billion USD |
| Reuters | $1.33 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Sino Medical Sciences Technology In
Sino Medical Sciences Technology Inc., a medical device company, engages in the research, development, production, and distribution of interventional medical devices in China. Its products include coronary drug stents, coronary balloons, intracranial rapid exchange balloons, and intracranial drug-eluting stents. The company was founded in 2007 and is headquartered in Tianjin, China.